Skip to Navigation
Skip to Main Content
Skip to Related Content

Advertisement

U.S. markets closed

S&P Futures
6,014.50
+27.50(+0.46%)
Dow Futures
44,648.00
+253.00(+0.57%)
Nasdaq Futures
20,962.00
+112.25(+0.54%)
Russell 2000 Futures
2,438.40
+24.80(+1.03%)
Crude Oil
71.22
-0.02(-0.03%)
Gold
2,701.20
-11.00(-0.41%)

Helius Medical Technologies, Inc. (HSDT)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD

Follow

Visitors trend2W10W9M

0.4532

+0.0027

(+0.60%)

At close: 04:00PM EST

0.4600

+0.01

(+1.50%)

After hours:

06:56PM EST

Currency in USD

Valuation Measures⁴

Market Cap (intraday)	1.69M
Enterprise Value	-1.76M
Trailing P/E	N/A
Forward P/E	N/A
PEG Ratio (5 yr expected)	N/A
Price/Sales (ttm)	1.76
Price/Book (mrq)	0.44
Enterprise Value/Revenue	N/A
Enterprise Value/EBITDA	N/A

Trading Information

Stock Price History

Beta (5Y Monthly)	1.61
52-Week Change ³	-92.88%
S&P500 52-Week Change ³	31.18%
52 Week High ³	9.5000
52 Week Low ³	0.3730
50-Day Moving Average ³	0.5671
200-Day Moving Average ³	2.2115

Share Statistics

Avg Vol (3 month) ³	451.61k
Avg Vol (10 day) ³	97.26k
Shares Outstanding ⁵	3.73M
Implied Shares Outstanding ⁶	3.73M
Float ⁸	3.56M
% Held by Insiders ¹	0.53%
% Held by Institutions ¹	5.87%
Shares Short (Oct 31, 2024) ⁴	225.38k
Short Ratio (Oct 31, 2024) ⁴	0.34
Short % of Float (Oct 31, 2024) ⁴	6.38%
Short % of Shares Outstanding (Oct 31, 2024) ⁴	6.30%
Shares Short (prior month Sep 30, 2024) ⁴	59.17k

Dividends & Splits

Forward Annual Dividend Rate ⁴	N/A
Forward Annual Dividend Yield ⁴	N/A
Trailing Annual Dividend Rate ³	0.00
Trailing Annual Dividend Yield ³	0.00%
5 Year Average Dividend Yield ⁴	N/A
Payout Ratio ⁴	0.00%
Dividend Date ³	Jan 04, 2021
Ex-Dividend Date ⁴	N/A
Last Split Factor ²	1:50
Last Split Date ³	Aug 17, 2023

Financial Highlights

Fiscal Year

Fiscal Year Ends	Dec 31, 2023
Most Recent Quarter (mrq)	Jun 30, 2024

Profitability

Profit Margin	0.00%
Operating Margin (ttm)	-1,796.70%

Management Effectiveness

Return on Assets (ttm)	-76.06%
Return on Equity (ttm)	-161.97%

Income Statement

Revenue (ttm)	594k
Revenue Per Share (ttm)	0.51
Quarterly Revenue Growth (yoy)	-28.90%
Gross Profit (ttm)	N/A
EBITDA	-11.83M
Net Income Avi to Common (ttm)	-8.84M
Diluted EPS (ttm)	-4.2700
Quarterly Earnings Growth (yoy)	N/A

Balance Sheet

Total Cash (mrq)	6.39M
Total Cash Per Share (mrq)	1.79
Total Debt (mrq)	35k
Total Debt/Equity (mrq)	0.55%
Current Ratio (mrq)	4.20
Book Value Per Share (mrq)	3.29

Cash Flow Statement

Operating Cash Flow (ttm)	-10.38M
Levered Free Cash Flow (ttm)	-5.85M